Welcome to Beacon Equity Research. Today is Wednesday, 9 January 2008
 Home   Covered Companies   News and Commentary   TraderNotes   Our Team   Ratings   Contact Us   Charity   Affiliates  
   


Beacon Research Issues TraderNotes on XSNX, NOEC, PYTO, CELG, AERO

Today’s TraderNotes include: XsunX, Inc. (OTCBB: XSNX), New Oriental Energy & Chemical Corp. (Nasdaq: NOEC), PhytoMedical Technologies, Inc. (OTCBB: PYTO), Celgene Corporation (Nasdaq: CELG), AeroGrow International, Inc. (Nasdaq: AERO)

 

XsunX, Inc. (XSNX) TraderNote – XSNX: Well-positioned in the Solar Cell Market With Strategic Alliance With MVSystems, Inc.

 

XsunX, Inc. (XSNX) closed last Friday at 0.59. So far today, the stock hit the high of 0.60 and is testing the 50% retracement level of its one-week range. XSNX is finding momentum in trading as it builds strategic alliance with MVSystems, Inc. XsunX, Inc. engages in the development, commercialization, and licensing of proprietary solar cell designs and core solar cell manufacturing systems. The company's designs and manufacturing systems enables licensees to manufacture advanced thin film solar devices on various substrates. It focuses on two primary solar cell device types for production that include Power Glass, for semi-transparent and opaque applications on both flexible and rigid substrates; and Hybrid 4-Terminal, for opaque applications rivaling silicon wafer efficiencies. The company primarily serves original equipment manufacturers in the thin film solar products market. In today's daily chart, XSNX's MACD indicator is in the positive zone with readings of both 12-day and 26-day EMAs above the 0 level, at 0.070 and 0.05, respectively. Slow Stochastics has confirmed an overbought condition, with readings of 65.84 %K and 79.28 %D, signaling a near-term selling signal but may retrace back upwards after touching psychological support level of 0.50. RSI is still in the bullish zone with a reading at 60.9, down from the 70% level, with near neutral indication.

 

New Oriental Energy & Chemical Corp. (NOEC) TraderNote – NOEC Gains Strong Demand From the Chemical, Pharmaceutical, Light, and Textile Industries

 

New Oriental Energy & Chemical Corp. (NOEC) closed last Friday at 7.43. So far today, the stock opened at 8.00 and hit the high of 8.59, while share prices registered a low of 7.00. New Oriental Energy & Chemical Corp., through its subsidiary, Henan Jinding Chemical Co., Ltd., engages in the manufacture and distribution of fertilizer and chemical products in the People's Republic of China. It offers urea and coal-based chemicals, including ammonium bicarbonate and liquid ammonia for nitrogenous fertilizers and raw materials of chemical products; methanol, which is used for the production of medicine, pesticide, dye, plastic, synthetic protein, fiber, formaldehyde, and methyl ether; and dimethyl ether that is used as an additive for liquefied petroleum gas (LPG) and non-industrial fuel substitute to LPG and for residential and automotive uses, and as refrigerant for refrigerators and air conditioners. The company serves chemical, pharmaceutical, light, and textile industries. New Oriental sells its products primarily through regional distributors. The 3-month range of NOEC's daily chart reflects a double-bottom, indicating a bullish signal for the stock. MACD indicator is in the positive zone with the histogram reading above 0.00 at 0.290, and the 12-day and 26-day EMAs positive at 0.425 and 0.135, respectively.

 

PhytoMedical Technologies, Inc. (PYTO) TraderNote – PYTO Finds Strength From Cooperative Research and Development Agreement in Developing Products

 

PhytoMedical Technologies, Inc. (PYTO) closed last Friday at 0.35. So far today PYTO is trading within the range of 0.32 – 0.38, with almost all technical indicators pointing north. PhytoMedical Technologies, Inc., together with its wholly owned subsidiaries, operates as an early stage research-based biopharmaceutical company. It focuses on the identification, acquisition, development, and commercialization of plant-derived pharmaceutical and nutraceutical compounds targeting cachexia, obesity, and diabetes. The company develops BDC-03, a plant derived compound that has capacity to decrease the deposition of fat and lower cholesterol. Additionally, through a cooperative research and development agreement, PhytoMedical engages in synthesizing the active components of various polyphenolic compounds found in cinnamon bark and characterizing their beneficial health effects in cell cultures systems, animals, and humans. RSI so far for PYTO's daily chart today is in the positive zone of 59.58, indicating a bullish signal and far from an overbought condition. MACD histogram is also in the positive zone of 0.007, indicating a bullish signal. RSI is also so far positive at 70.36, with no confirmation of an overbought condition. Slow Stochastics indicator is likewise in the positive zone, with %K at 82.54 and %D at 58.91, indicating a continuation in upward trend.

 

Celgene Corporation (CELG) TraderNote – CELG Boosted by Its Products for the Treatment of Cancer and Immune-inflammatory Related Diseases

 

Celgene Corporation (CELG) closed last Friday at 49.65. For today, share prices opened at 52.26 and hit the high so far of 52.69. Celgene Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of innovative therapies to treat cancer and immune-inflammatory related diseases in Europe and the United States. Its lead products include THALOMID for the treatment and suppression of cutaneous manifestations of erythema nodosum leprosum, an inflammatory complication of leprosy. The company's products also include REVLIMID for the treatment of patients with transfusion-dependent anemia; FOCALIN for attention deficit hyperactivity disorder in children and adolescents; and ALKERAN for the treatment of hematological diseases. Its products in pipeline primarily include CC-10004, a Phase II clinical trial product for psoriasis and psoriatic arthritis; CC-11050, a Phase I trial product for the treatment of inflammatory diseases; and CC-10015, CC-13097, and CC-15965, the pre-clinical stage products for the treatment of inflammatory diseases. In today's daily chart, CELG's MACD is in the positive zone with histogram reading above 0 level at 0.726 but with the trend-line 9-day EMA trading below the 0 level, indicating a weak bullish signal. Slow stocahstics is likewise positive, with readings of 85.35 %K and 74.23 %D, still to confirm an overbought condition. RSI at 45.14 indicates a bearish signal or move towards the downtrend.

 

AeroGrow International, Inc. (AERO) TraderNote – AERO Forecasts Revenue of Approximately $14 Million to $14.5 Million for Q3 Ending December 31

 

AeroGrow International, Inc. (AERO) closed last Friday at 6.17. With the opening price at 6.30, AERO hit the high of 6.75 so far today. AeroGrow International, Inc. engages in the development, marketing, and distribution of indoor aeroponic garden systems for gardening, cooking and small kitchen appliance, healthy eating, and home and office decor markets worldwide. Its principal products include kitchen garden indoor growing systems and proprietary seed kits and accessories that allow consumers to grow cherry tomatoes, cilantro, chives, basil, dill, oregano, mint, flowers, chili peppers, salad greens, and vegetables. The company also offers rainforest nutrient delivery system to provide aeroponic plant growth; pre-seeded bio-grow seed pods; microprocessor-based control panel and nutrient cycle delivery system; time-release nutrient tablets; automatic water adjustment; integrated and automated lighting system; and adaptive growth software. The company continues to grow as it recently forecasts revenue of about $14 million to $14.5 million for three months ended December 31. For today, so far the RSI indicator of AERO's daily chart is in the positive zone of 60.35, indicating a bullish signal and far from an overbought condition. Slow stochastics also indicates a bullish signal, with readings of 77.46 %K and 73.81 %D, both lines directed upwards almost touching the 80% level but with no confirmation of an overbought condition. MACD likewise indicates a bullish signal, with histogram reading at 0.08, and the %K at 77.46 and %D at 73.81, all above the 0.00 level to indicate an uptrend.

 

Beacon Equity Research Disclosure

 

The analysts contributing to this report do not hold any shares of XsunX Inc. (XSNX). Additionally the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research (“Beacon”) certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon Equity Research and its affiliates have been directly compensated a total of fifteen thousand dollars directly from the company for enrollment of XSNX in its research program and other services. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.

Comments (0)

Write comment
smaller | bigger


Write the displayed characters


 
< Prev   Next >

 
Copyright 2007 Beacon Equity Research